Barclays Upgrades Oscar Health as Managed Care Outlook Improves
Barclays upgraded Oscar Health to Equal Weight, raising its price target to $18 as analysts see margin expansion and renewed interest in managed care stocks in 2026.
/ 7 items
#OSCR↓
Senate Fails to Save Obamacare Subsidies; Premiums Will Soar
Over 20 million Americans face sharply higher health insurance costs after the Senate rejected both Republican and Democratic plans to extend expiring Affordable Care Act tax credits.
Piper Sandler Upgrades Oscar Health to Overweight, Sees Strong Profit Potential
Piper Sandler upgrades Oscar Health to Overweight with a $25 price target, citing growth and profitability potential through 2027.
White House to Propose 2-Year Obamacare Subsidy Extension with New Restrictions
White House plans to unveil health policy framework extending ACA subsidies for two years while adding income caps and minimum premium requirements to address expiring benefits.
Trump's Attack on Health Insurers Sends Stocks Tumbling
Health insurance stocks dropped during pre-market trading after President Trump criticized insurers on social media and proposed providing direct subsidies to consumers instead of ACA tax credits.
Oscar Health Posts $137M Q3 Loss But Eyes 2026 Profitability Return
Oscar Health reports third quarter loss amid rising healthcare costs but plans return to profitability in 2026 through rate increases and market expansion in ACA insurance space.